Miti Health wins a D-Prize!

We are thrilled to announce that we have won a D-Prize. D-Prize is a tremendous organization provides funding to pilot and test early-stage ideas that are working to improve distribution of proven technologies. The process of applying for this award was one of the most intense and rewarding that we’ve experienced so far.

D-Prize-Logo-Banner1

Before we applied for the D-Prize, our young organization had primarily been focused on designing and building a technology. As we focused on specifics of how technology could support healthcare providers, we sometimes lost focus on the bigger picture. The D-Prize process guided us to think about the larger context, the business model, and how we could use a basic piece of technology to improve and streamline supply chains across East Africa. We are excited to join the D-Prize community and gain guidance and support as we refine our model. A huge thanks to the D-Prize team and to our new mentor, John Yi!

By |April 25th, 2014|Announcements, Awards|0 Comments

Miti Health wins a CIGH Pilot Project Award!

Miti Health is honored and delighted to announce that we have received additional support from Stanford through the Center for Innovation in Global Health (CIGH) Pilot Project Awards.  Both CIGH and the Biodesign program have been incredible supporters of ours from the very start.

Stanford Biodesign Logo CIGH

After our customer research in Kenya last summer, we had some time to reflect, and we realized how much fragmentation and inefficiencies in the medication supply chain in Kenya were adversely affecting health outcomes for patients.  The pharmacists that we met were constantly running out of medication and often needed to reorder medication every single day, working with an average of 6 different suppliers to get the medication that they needed.  And in many cases, they had very little information about the quality of drugs that they were receiving.  Given what we found in our market research, we weren’t surprised to learn that 30% of medication distributed in Africa is counterfeit or substandard – with such a fragmented and ad-hoc system, how could patients or pharmacists know which drugs were good?

As we thought more about this huge problem, we realized that we needed to learn more and design our system to specifically address this issue.  We were lucky that someone with incredible supply chain expertise was interested in leading this work, and that Stanford was once-again willing to throw support behind an energetic team with a crazy idea.  And we’re excited to share what we learn and the systems that we design.

By |March 10th, 2014|Announcements, Awards|0 Comments